S100A14 protein as diagnostic and prognostic marker in hepatocellular carcinoma
Abstract Background Protein S100A14 has recently been implicated in the progress of several types of cancers. This study aimed to investigate the clinical significance of S100A14 in the diagnosis of hepatocellular carcinoma (HCC). Results S100A14 was significantly elevated in the HCC group. A cut-of...
Main Authors: | Basma Fathy Mohamed, Waleed Mohamed Serag, Reda Mahamoud Abdelal, Heba Fadl Elsergany |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-12-01
|
Series: | Egyptian Liver Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43066-019-0015-6 |
Similar Items
-
S100A14 serum level and its correlation with prognostic factors in breast cancer
by: Noor Al-Ashkar, et al.
Published: (2020-09-01) -
Detection of liver fibrosis stages in patients with hepatitis C virus infection by non-invasive tool
by: Waleed Mohamed Serag, et al.
Published: (2021-01-01) -
S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function
by: Xiaoxuan Tu, et al.
Published: (2024-03-01) -
Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients
by: Mahmoud El-Bendary, et al.
Published: (2023-08-01) -
Assessment of Plasma Vitronectin as Diagnostic and Prognostic Marker of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Cirrhosis
by: Salem Youssef Mohamed, et al.
Published: (2022-01-01)